Psychotherapy for OCD You're a cutting edge psychiatrist. Not only are you great with meds, but you have a passing knowledge of CBT (cognitive-behavior therapy) techniques for the ...
Cognitive Behavior Therapy for Psychiatrists When it comes to cognitive behavior therapy (CBT) and most psychiatrists, a little knowledge is a troubling thing. We know that CBT is ...
Treating Adolescent Depression With Psychotherapy: The Three T’s Adolescence is a time of increased vulnerability for depression, with risk factors driven by biological, cognitive, and social-environmental changes in development. More than half of all adolescents report experiencing depressed mood, and 8% to 10% experience clinically diagnosable symptoms.1 Depression in the young negatively affects all areas of development, including academic, cognitive, social, and family functioning, and if untreated, it can have significant lasting consequences.
Top Research Findings That Can Change Clinical Practice Psychiatrists and other clinical providers are under increasing pressure to stay current. With the fast growth of knowledge, the challenge to keep up with the ever-growing body of information is greater than ever. There is an emerging realization that, as clinical providers, we need help in sorting and evaluating the quality of information before we can apply it to clinical practice.
Panic-Focused Psychodynamic Psychotherapy Both cognitive-behavioral1-3 and pharmacological4-6 treatments for panic disorder have been found to be effective over the short term. Not all patients, however, can tolerate or fully respond to these approaches,1-3,7,8 and the effectiveness of these interventions over the long term remains unclear.1,9
The Basic Principles of Cognitive Behavior Therapy Although therapy must be tailored to the individual, there are, nevertheless, certain principles that underlie cognitive behavior therapy for all ...
The ABCs of Cognitive-Behavioral Therapy for Schizophrenia Cognitive-behavioral therapy (CBT) in schizophrenia was originally developed to provide additional treatment for residual symptoms, drawing on the principles and intervention strategies previously developed for anxiety and depression.
Reasons Patients Doubt Medication-Resistant Delusions in Schizophrenia An estimated 25% to 50% of patients with schizophrenia experience residual symptoms, including medication-resistant delusions.1,2 These persistent symptoms contribute to the chronic, debilitating course of the illness. Delusions are defined as “fixed false beliefs” that have the following attributes3:
Combining High-Yield CBT Methods and Pharmacotherapy in Brief Sessions As psychiatric practice moves increasingly to brief treatment sessions, fewer psychiatric office visits are being devoted to providing traditional-length psychotherapy.1 Yet, there are many reasons to consider using psychotherapeutic methods in the briefer sessions that dominate contemporary clinical practice.2-6 A primary reason is the lack of full symptom control from psychopharmacological treatment for a large number of patients.
